Compound class:
Synthetic organic
Comment: This compound is a particularly preferred example in patent US8664233 [1] which covers compounds for use in treating non-solid malignant hematological tumours, in particular, B cell leukemias.
|
|
References |
1. Reichelt C, Schulze A, Daghish M, Ludwig F-A, Heinicke J, Herrmann K, Schuster M, Letschert S, Mugridge K, DeAngelo J. (2014)
Substituted 5H-pyrimido[5,4-B]indoles, method for the production thereof and use thereof for treating non-solid malignant tumors of the blood-producing system. Patent number: US8664233. Assignee: The Medicines Company (Leipzig) Gmbh. Priority date: 22/12/2006. Publication date: 04/03/2014. |